Platform is touted as being flexible for project planning and having quality-control advantages.
Eurofins MWG Operon expanded its sequencing capacity with a Roche GS Junior. The GS Junior is the optimum system for sequencing smaller-scale projects that require only one-eighth of the capacity of a GS FLX Titanium run or that would not be suitable for an Illumina run, according to Roche and Eurofins.
As a consequence, the GS Junior adds a higher degree of flexibility in project planning and will have a positive impact on the turnaround time for small-sized initiatives, Eurofins states. In addition, it allows new possibilities in quality control, e.g., library checking in advance of starting high-throughput sequencing or the validation of next-generation sequencing (NGS) data for molecular diagnostics.
“We are pleased to integrate this new system in our NGS service pipeline,” says Bruno Poddevin, Eurofins svp, Genomic Services. “It allows our customers to plan experiments that have not been possible in this short timeframe before. In addition, it will secure the high quality of our high-throughput sequencing projects and allow us to develop new applications in a reasonable time and at reasonable cost.”